PharmiNews

Directory of Pharma Companies and News

Company Profile

Imugene

Imugene logo
Category
Imugene (ASX:IMU) is a clinical stage immuno-oncology company headquartered in Melbourne, Australia. Its lead product is HER-Vaxx, a B Cell peptide vaccine for the treatment of gastric cancer. The company is also developing mimotope-based immunotherapies against validated and new oncology targets.
Keywords:
0 results
Brought to you by PharmiWeb.com - Latest Jobs in Pharma